Telesis Bio(TBIO.US)

Last Updated 19:00:00 ET
longbridge loading

Biotalys Reports Full-Year 2025 Financial Results and Business Highlights

Unusual Whales·
US
BTAI
+3.67%
US
TBIO
0.00%
US
TLIS
0.00%
Unusual Whales·
US
BTAI
+3.67%
US
TBIO
0.00%
US
TLIS
0.00%

Terremoto wins $108m in Series C to drive cancer and rare disease programmes

Pharmaceutical Technology·
US
TBIO
0.00%
US
MBX
+1.43%
US
FBT
+0.93%
Pharmaceutical Technology·
US
TBIO
0.00%
US
MBX
+1.43%
US
FBT
+0.93%

Telesia Extends Timetable for 2025 Accounts and Updates 2026 Financial Calendar

Tip Ranks·
US
LABU
+3.11%
US
IBB
+0.92%
US
XBI
+1.07%
Tip Ranks·
US
LABU
+3.11%
US
IBB
+0.92%
US
XBI
+1.07%

Satellos Bioscience Unveils Positive Interim SAT-3247 Data in Duchenne Muscular Dystrophy at MDA 2026

Tip Ranks·
US
XBI
+1.07%
US
ASMB
-0.53%
US
FBT
+0.93%
Tip Ranks·
US
XBI
+1.07%
US
ASMB
-0.53%
US
FBT
+0.93%

Satellos to Host February 24 Virtual KOL Event Showcasing SAT-3247 in Duchenne Muscular Dystrophy

Tip Ranks·
US
TBIO
0.00%
US
XBI
+1.07%
US
IBB
+0.92%
Tip Ranks·
US
TBIO
0.00%
US
XBI
+1.07%
US
IBB
+0.92%

Stocks in Play: Satellos Bioscience Inc.

Baystreet·
US
IBB
+0.92%
US
SBIO
+1.57%
US
ASMB
-0.53%
Baystreet·
US
IBB
+0.92%
US
SBIO
+1.57%
US
ASMB
-0.53%
© 2026 Longbridge｜Disclaimer